Efficacy News and Research

RSS
ERYTECH reports fast take-off of GRASPA Phase IIb trial in patients with acute myeloid leukemia

ERYTECH reports fast take-off of GRASPA Phase IIb trial in patients with acute myeloid leukemia

Adding chemotherapy after surgery for patients with advanced gastric cancer can reduce mortality risk

Adding chemotherapy after surgery for patients with advanced gastric cancer can reduce mortality risk

Researchers produce potential antibiotic that targets bacterial enzyme critical to metabolic processes

Researchers produce potential antibiotic that targets bacterial enzyme critical to metabolic processes

Telemonitoring with pharmacist management improves and maintains BP control

Telemonitoring with pharmacist management improves and maintains BP control

Imaxio receives FP7 grant to support the development of S. aureus vaccine

Imaxio receives FP7 grant to support the development of S. aureus vaccine

Study says screening heart with natriuretic peptide may reduce risk of dysfunction, heart failure

Study says screening heart with natriuretic peptide may reduce risk of dysfunction, heart failure

CTI announces publication of preclinical, clinical data for pacritinib in Drugs of the Future 2013

CTI announces publication of preclinical, clinical data for pacritinib in Drugs of the Future 2013

Nearly half a million dollars given to physicians working to cure psoriatic diseases

Nearly half a million dollars given to physicians working to cure psoriatic diseases

Biogen, Sobi present new findings from Phase 3 trial of ALPROLIX at XXIV ISTH Congress

Biogen, Sobi present new findings from Phase 3 trial of ALPROLIX at XXIV ISTH Congress

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

FDA sends Complete Response Letter to Merck regarding investigational drug for insomnia

FDA sends Complete Response Letter to Merck regarding investigational drug for insomnia

UNC scientists use GEMMs to develop biomarkers for molecular subtypes of human breast cancer

UNC scientists use GEMMs to develop biomarkers for molecular subtypes of human breast cancer

SBRT treatment safe and effective for stage I NSCLC, study finds

SBRT treatment safe and effective for stage I NSCLC, study finds

OBI advances Phase IIb clinical trial of Oxycyte for treatment of TBI

OBI advances Phase IIb clinical trial of Oxycyte for treatment of TBI

New report shows steady progress in research and development for HIV vaccines

New report shows steady progress in research and development for HIV vaccines

RPCI scientists assess safety and efficacy of immunotherapy approach to treat advanced melanoma

RPCI scientists assess safety and efficacy of immunotherapy approach to treat advanced melanoma

Transplanted bone marrow stem cells in patients with type 2 diabetes reduce insulin use

Transplanted bone marrow stem cells in patients with type 2 diabetes reduce insulin use

Innovative procedure for atrial fibrillation reduces risk for stroke

Innovative procedure for atrial fibrillation reduces risk for stroke

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.